Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07724899) titled 'Efficacy and Safety of Superior Vena Cava Isolation and Pulmonary Vein Isolation for Treatment of Atrial Fibrillation' on July 21.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).

Primary Sponsor: Qiang Hu

Condition: Atrial Fibrillation (AF)

Intervention: Procedure: superior vena cava isolation plus pulmonary Vein isolation

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: July 20, 2026

Target Sample Size: 200

Countries of Recruitment: Ch...